Clinical trials
Phase 1 beta-Thalassemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 4 |
| Terminated | 4 |
| Active, not recruiting | 1 |
| Withdrawn | 1 |
| Unknown status | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| CorrectSequence Therapeutics Co., Ltd | 3 |
| Abdullah Kutlar | 1 |
| Assiut University | 1 |
| Beni-Suef University | 1 |
| Celgene | 1 |
| Children's Hospital of Fudan University | 1 |
| Daniel Bauer | 1 |
| David Williams | 1 |
| EdiGene (GuangZhou) Inc. | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 22 |
| Anemia, Sickle Cell | 9 |
| Iron Overload | 2 |
| Thalassemia | 2 |
| Anemia, Aplastic | 1 |
| Anemia, Diamond-Blackfan | 1 |
| Chediak-Higashi Syndrome | 1 |
| Dyskeratosis Congenita | 1 |
| Fanconi Anemia | 1 |
| Granulomatous Disease, Chronic | 1 |
Trials
Showing 51 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.